Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Mission

Early Stage Partners is proud to serve our limited partners and to support leading technology companies in the Midwest. 

We believe that by providing much-needed capital, advice and connections to promising early stage companies, we can breed success for entrepreneurs, investors and the region as a whole.

Find Out More About ESP

News & Events

Lynn-Ann Gries joins ESP


June 15, 2016

Early Stage partners welcomes Lynn-Ann Gries, an experienced early stage investor who will lead the investment activities of ESP Fund III.

OnShift Raises Series D


April 13, 2016

OnShift Raises $18M in Series D Financing

Juventas Therapeutics, Inc.


February 04, 2016

1st patient in Phase 2 Trial for Treatment of Advanced Peripheral Artery Disease

Blue Spark Technologies


December 16, 2015

Temp Traq is changing the way parents and childcare professionals monitor a baby's temperature through modern technology.